U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07198126) titled 'Comparison Of Keratometric Readings Pre and Post Pterygium Excision With Conjunctival Autogr... Read More
U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07197957) titled 'Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury' on Sept. 25. Brief S... Read More
U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199400) titled 'Using a Technology Assisted Physical Activity Program to Improve Muscle Strength, Joint Mobi... Read More
U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07200102) titled 'Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma' on Sept. 22. Brief Summ... Read More
U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199153) titled 'Accuracy of 3D Printed Custom-Made Registration Method for Dynamic Navigation Implant Surger... Read More
Mumbai, Oct. 1 -- Israel's Consul General to India, Yaniv Revach highlighted the shared experiences of India and Israel in combating terrorism. Speaking with ANI, Revach expressed gratitude for India... Read More
, Oct. 1 -- The body of a grocer who had been missing for three days was recovered from a paddy field in Zakiganj upazila of Sylhet on Wednesday afternoon. The deceased was identified as Noman Uddin ... Read More
New Delhi, Oct. 1 -- Microsoft, on Wednesday, appointed its Chief Commerical Officer (CCO), Judson Althoff as CEO of the commercial business, freeing up the tech giant's chief Satya Nadella to focus m... Read More
Chandigarh, Oct. 1 -- A grand Bada Khana was organised, bringing together around 800 police personnel for a traditional dinner symbolising unity, camaraderie, and brotherhood in the force. The event ... Read More
New Delhi, Oct. 1 -- The Central Drugs Standard Control Organisation (CDSCO), India's drug controller, has Ozempic (semaglutide) for use in adults with type-2 diabetes. The Ozempic launch in India com... Read More